<HTML>
<!-- Produced by EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2020 [PPXK611ND10HVJWTAWPF]. www.edgarsuite.com -->
<HEAD>
</HEAD>
<BODY>
<DIV style=margin-left:72pt;width:454.5pt><P style='font:12pt stHtmlOvrFontNm;margin:0'><A name=FIS_FORM /><FONT style=font-size:5pt>&#160;</FONT></P>
<P style='font:12pt stHtmlOvrFontNm;margin-top:2pt;margin-bottom:0pt'><FONT style=font-size:5pt>&#160;</FONT><A name=FIS_UNIDENTIFIED_TABLE /></P>
<P align=center style='font:12pt stHtmlOvrFontNm;margin-top:12pt;margin-bottom:0pt'><FONT style=font-size:14pt><B>UNITED STATES</B></FONT><BR><FONT style=font-size:14pt><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT></P>
<P align=center style='font:12pt stHtmlOvrFontNm;margin:0'><B>Washington, D.C. 20549</B></P>
<P align=center style='font:12pt stHtmlOvrFontNm;margin-top:16.75pt;margin-bottom:0pt;margin-left:213pt;margin-right:213pt'><FONT style=font-size:5pt><B>&#160;</B></FONT></P>
<P align=center style='font:12pt stHtmlOvrFontNm;margin-top:12pt;margin-bottom:0pt'><FONT style=font-size:18pt><B>FORM 8-K</B></FONT></P>
<P align=center style='font:12pt stHtmlOvrFontNm;margin-top:16.75pt;margin-bottom:0pt;margin-left:213pt;margin-right:213pt'><FONT style=font-size:5pt>&#160;</FONT></P>
<P align=center style='font:12pt stHtmlOvrFontNm;margin-top:12pt;margin-bottom:0pt'><B>CURRENT REPORT</B><BR><B>Pursuant to Section&#160;13 or 15(d) of the</B><BR><B>Securities Exchange Act Of 1934</B></P>
<P align=center style='font:12pt stHtmlOvrFontNm;margin-top:12pt;margin-bottom:0pt'><FONT style=font-size:10pt><B>Date of Report (Date of earliest event reported</B><B>): </B><B>September 10</B><B>, 2020</B></FONT></P>
<P align=center style='font:10pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
<P align=center style='font:18pt stHtmlOvrFontNm;margin:0'><B>VERDE BIO HOLDINGS, INC.</B></P>
<P align=center style='font:12pt stHtmlOvrFontNm;margin:0'><FONT style=font-size:10pt>(Exact Name of Registrant as Specified in Charter)</FONT></P>
<TABLE style=border-collapse:collapse;width:424.65pt><TR><TD valign=bottom style=width:139.5pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=bottom style=width:1pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=bottom style=width:172.3pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=bottom style=width:29.55pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=bottom style=width:82.3pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:139.5pt><P align=center style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt><B>Nevada</B></FONT></P>
</TD><TD valign=bottom style=width:1pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:172.3pt><P align=center style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt><B>000-54524</B></FONT></P>
</TD><TD valign=bottom style=width:29.55pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:82.3pt><P align=center style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt><B>30-0678378</B></FONT></P>
</TD></TR>
<TR><TD valign=top style=width:139.5pt><P align=center style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>(State or Other Jurisdiction</FONT><BR><FONT style=font-size:10pt>of Incorporation)</FONT></P>
</TD><TD valign=bottom style=width:1pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:172.3pt><P align=center style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>(Commission</FONT><BR><FONT style=font-size:10pt>File Number)</FONT></P>
</TD><TD valign=bottom style=width:29.55pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:82.3pt><P align=center style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>(IRS Employer</FONT><BR><FONT style=font-size:10pt>Identification No.)</FONT></P>
</TD></TR>
</TABLE>
<P align=center style='font:11pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
<P align=center style='font:11pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
<P align=center style='font:10pt stHtmlOvrFontNm;margin:0;color:#000000'><A name=_Hlk482194689 /><B>5 Cowboys Way, Suite 300</B></P>
<P align=center style='font:12pt stHtmlOvrFontNm;margin:0'><FONT style=font-size:10pt><B>Frisco</B><B> </B><B>TX</B><B> </B><B>75034</B></FONT></P>
<P align=center style='font:12pt stHtmlOvrFontNm;margin:0'><FONT style=font-size:10pt>(Address of Principal Executive Offices)</FONT></P>
<P align=center style='font:10pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
<P style='font:10pt stHtmlOvrFontNm;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:12pt stHtmlOvrFontNm;margin:0'><FONT style=font-size:10pt><B>(972) 217-4080</B></FONT></P>
<P align=center style='font:10pt stHtmlOvrFontNm;margin:0'>(Registrant&#8217;s Telephone Number, Including Area Code)</P>
<P align=center style='font:10pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
<P style='font:10pt stHtmlOvrFontNm;margin-top:6pt;margin-bottom:0pt'>&nbsp;</P>
<P style='font:10pt stHtmlOvrFontNm;margin-top:6pt;margin-bottom:0pt'>&nbsp;</P>
<P style='font:12pt stHtmlOvrFontNm;margin-top:6pt;margin-bottom:0pt'><FONT style=font-size:10pt>Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (<I>see</I> General Instruction A.2. below):</FONT></P>
<P style='font:12pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse><TR><TD valign=top style=width:9.6pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style='font:10pt Wingdings'>&#111;</FONT></P>
</TD><TD valign=top style=width:6.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:559.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>Written communications pursuant to Rule&#160;425 under the Securities Act (17 CFR 230.425)</FONT></P>
</TD></TR>
<TR><TD valign=middle style=width:9.6pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:6pt>&#160;</FONT></P>
</TD><TD colspan=2 valign=top style=width:566.4pt><P style='font:12pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:9.6pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style='font:10pt Wingdings'>&#111;</FONT></P>
</TD><TD valign=top style=width:6.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:559.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>Soliciting material pursuant to Rule&#160;14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></P>
</TD></TR>
<TR><TD valign=middle style=width:9.6pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:6pt>&#160;</FONT></P>
</TD><TD colspan=2 valign=top style=width:566.4pt><P style='font:12pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:9.6pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style='font:10pt Wingdings'>&#111;</FONT></P>
</TD><TD valign=top style=width:6.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:559.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>Pre-commencement communications pursuant to Rule&#160;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></P>
</TD></TR>
<TR><TD valign=middle style=width:9.6pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:6pt>&#160;</FONT></P>
</TD><TD colspan=2 valign=top style=width:566.4pt><P style='font:12pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
</TD></TR>
<TR><TD valign=top style=width:9.6pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style='font:10pt Wingdings'>&#111;</FONT></P>
</TD><TD valign=top style=width:6.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:559.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>Pre-commencement communications pursuant to Rule&#160;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></P>
</TD></TR>
</TABLE>
<P style='font:12pt stHtmlOvrFontNm;margin-top:10pt;margin-bottom:0pt'><FONT style=font-size:5pt>&#160;</FONT></P>
<P style='font:12pt stHtmlOvrFontNm;margin-top:1pt;margin-bottom:0pt'><FONT style=font-size:5pt>&#160;</FONT></P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:12pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
<P style='font:10pt stHtmlOvrFontNm;margin:0'><A name=FIS_SECTION_5_CORPORATE_GOVERNANCE /><A name=FIS_CHANGE_IN_DIRECTORS_OR_PRINCIPAL_OFF /><B>Item 1.01 Entry into a Material Definitive Agreement.</B></P>
<P style='font:10pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
<P style='font:10pt stHtmlOvrFontNm;margin:0'><B>Debt Financing</B></P>
<P align=justify style='font:10pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt stHtmlOvrFontNm;margin:0;text-indent:36pt'>Effective September 11, 2020, Verde Bio Holdings, Inc. (the &#8220;Company&#8221;) entered into a Securities Purchase Agreement dated September 10, 2020 (&#8220;Purchase Agreement&#8221;) with GHS Investments, LLC (&#8220;GHS&#8221;). In conjunction with the Purchase Agreement, the Company has signed a Convertible Promissory Note for $35,000 (the &#8220;Note&#8221;). &nbsp;The Note contains an interest rate of ten percent (10%) per annum and has a maturity date of nine months following the date the funds are received. &nbsp;The amounts due under the Note are convertible at any time prior to the Maturity Date at a rate of 60% of the market price on the date prior to the execution of the Note.</P>
<P align=justify style='font:10pt stHtmlOvrFontNm;margin:0;text-indent:36pt'> &nbsp;</P>
<P align=justify style='font:10pt stHtmlOvrFontNm;margin:0;text-indent:36pt'>A form of the Purchase Agreement and Note are filed as Exhibits 10.1 and 10.2 to this Current Report on Form 8-K.</P>
<TABLE style=border-collapse:collapse;width:558pt><TR><TD valign=top style=width:57.3pt><P style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
<P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt><B>Item&#160;</B><B>3.02</B></FONT></P>
</TD><TD valign=top style=width:6.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:494pt><P style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
<P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt><B>Unregistered Sales of Equity Securities</B><B>.</B></FONT></P>
</TD></TR>
</TABLE>
<P style='font:10pt stHtmlOvrFontNm;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt stHtmlOvrFontNm;margin:0;text-indent:36pt'>The information regarding the Subscription Agreement and the purchase of the Shares set forth in Item 1.01 is incorporated by reference into this Item 3.02.</P>
<P style='font:10pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:576pt><TR><TD valign=top style=width:57.3pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt><B>Item&#160;9.01</B></FONT></P>
</TD><TD valign=top style=width:6.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:512pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt><B>Financial Statements and Exhibits.</B></FONT></P>
</TD></TR>
</TABLE>
<P style='font:10pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
<P style='font:12pt stHtmlOvrFontNm;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'>Exhibits</FONT><FONT style=font-size:10pt>. The following exhibits are being filed herewith:</FONT></P>
<P style='font:12pt stHtmlOvrFontNm;margin:0'>&nbsp;</P>
<TABLE style=border-collapse:collapse;width:463.5pt><TR><TD valign=top style=width:35.3pt><P style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style='border-bottom:1px solid #000000'>&#160;Exhibit Number</FONT></P>
<P style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
<P align=center style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>10.1</P>
<P align=center style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
<P align=center style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>10.2</P>
<P align=center style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
<P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
</TD><TD valign=top style=width:23.55pt><P style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
<P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
<P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
</TD><TD valign=top style=width:22.15pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:382.5pt><P align=center style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
<P style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style='border-bottom:1px solid #000000'>Description of Exhibits</FONT></P>
<P align=center style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
<P style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><A href=vbhi_ex10z1.htm style=text-decoration:none><FONT style='color:#0000FF;border-bottom:1px solid #0000FF'>Securities Purchase Agreement.</FONT></A></P>
<P style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
<P style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><A href=vbhi_ex10z2.htm style=text-decoration:none><FONT style='color:#0000FF;border-bottom:1px solid #0000FF'>Convertible Promissory Note</FONT></A>.</P>
<P style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
<P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
<P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'>&nbsp;</P>
</TD></TR>
</TABLE>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style=line-height:0;margin:0></P>
<P style='font:12pt stHtmlOvrFontNm;margin:0'><A name=eolPage3 /><FONT style=font-size:8pt><B>&#160;</B></FONT></P>
<P align=center style='font:12pt stHtmlOvrFontNm;margin-top:18pt;margin-bottom:0pt'><A name=FIS_SIGNATURES /><FONT style=font-size:10pt><B>SIGNATURES</B></FONT></P>
<P style='font:12pt stHtmlOvrFontNm;margin-top:6pt;margin-bottom:0pt'><FONT style=font-size:10pt>&#160;&#160;&#160;&#160;&#160;Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized, on the 25th day of September, 2020.</FONT></P>
<TABLE style=border-collapse:collapse><TR><TD valign=middle style=width:241.8pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=middle style=width:29.15pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=middle style=width:46.05pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=middle style=width:182.3pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=middle style=width:76.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD></TR>
<TR><TD valign=top style=width:241.8pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD colspan=3 valign=middle style=width:257.5pt><P style='font:10pt stHtmlOvrFontNm;margin:0;margin-right:2.8pt'>VERDE BIO HOLDINGS, INC.<BR></P>
<P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:2.8pt'>&nbsp;</P>
</TD><TD valign=middle style=width:76.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD></TR>
<TR><TD valign=middle style=width:241.8pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:29.15pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>By:&#160;&#160;</FONT></P>
</TD><TD colspan=2 valign=middle style='width:228.35pt;border-bottom:0.75pt solid #000000'><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:1.8pt'><FONT style=font-size:10pt>/s/ Scott Cox &#160;</FONT></P>
</TD><TD valign=middle style=width:76.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD></TR>
<TR><TD valign=middle style=width:241.8pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=middle style=width:29.15pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:46.05pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>Name:&#160;&#160;</FONT></P>
</TD><TD valign=middle style=width:182.3pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>Scott Cox</FONT></P>
</TD><TD valign=middle style=width:76.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD></TR>
<TR><TD valign=middle style=width:241.8pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=middle style=width:29.15pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD><TD valign=top style=width:46.05pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>Title:&#160;&#160;</FONT></P>
</TD><TD valign=middle style=width:182.3pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>Chief Executive Officer&#160;</FONT></P>
</TD><TD valign=middle style=width:76.7pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:0.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD></TR>
<TR><TD colspan=5 valign=middle style=width:576pt><P style='font:12pt stHtmlOvrFontNm;margin:0;margin-right:4.8pt'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD></TR>
</TABLE>
<P align=center style='font:12pt stHtmlOvrFontNm;margin-top:11.25pt;margin-bottom:0pt'><FONT style=font-size:10pt> &#160;&nbsp;</FONT></P>
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "vbhi_8k.htm", "description": "FORM 8-K", "secsgml_size_bytes": 20200}]
{"company-data": {"conformed-name": "VERDE BIO HOLDINGS, INC.", "cik": "0001490054", "assigned-sic": "7371", "irs-number": "300678378", "fiscal-year-end": "0430"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-54524", "film-number": "201201601"}, "business-address": {"street1": "358 SOUTH 300 EAST", "city": "SALT LAKE CITY", "state": "UT", "zip": "84111", "phone": "(205) 864-5377"}, "mail-address": {"street1": "358 SOUTH 300 EAST", "city": "SALT LAKE CITY", "state": "UT", "zip": "84111"}, "former-company": {"former-conformed-name": "APPIPHANY TECHNOLOGIES HOLDINGS CORP", "date-changed": "20100421"}}
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act Of 1934
Date of Report (Date of earliest event reported
):
September 10
, 2020
VERDE BIO HOLDINGS, INC.
(Exact Name of Registrant as Specified in Charter)
Nevada
000-54524
30-0678378
(State or Other Jurisdiction
of Incorporation)
(Commission
File Number)
(IRS Employer
Identification No.)
5 Cowboys Way, Suite 300
Frisco
TX
75034
(Address of Principal Executive Offices)
(972) 217-4080
(Registrant's Telephone Number, Including Area Code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (
see
General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 1.01 Entry into a Material Definitive Agreement.
Debt Financing
Effective September 11, 2020, Verde Bio Holdings, Inc. (the "Company") entered into a Securities Purchase Agreement dated September 10, 2020 ("Purchase Agreement") with GHS Investments, LLC ("GHS"). In conjunction with the Purchase Agreement, the Company has signed a Convertible Promissory Note for $35,000 (the "Note").  The Note contains an interest rate of ten percent (10%) per annum and has a maturity date of nine months following the date the funds are received.  The amounts due under the Note are convertible at any time prior to the Maturity Date at a rate of 60% of the market price on the date prior to the execution of the Note.
A form of the Purchase Agreement and Note are filed as Exhibits 10.1 and 10.2 to this Current Report on Form 8-K.
Item
3.02
Unregistered Sales of Equity Securities
.
The information regarding the Subscription Agreement and the purchase of the Shares set forth in Item 1.01 is incorporated by reference into this Item 3.02.
Item 9.01
Financial Statements and Exhibits.
Exhibits
. The following exhibits are being filed herewith:
Exhibit Number
10.1
10.2
Description of Exhibits
Securities Purchase Agreement.
Convertible Promissory Note
.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, hereunto duly authorized, on the 25th day of September, 2020.
VERDE BIO HOLDINGS, INC.
By:
/s/ Scott Cox
Name:
Scott Cox
Title:
Chief Executive Officer